Mike Biotech: Announcement on the completion of the general election of the board of directors and the board of supervisors and the appointment of senior management and securities affairs representatives
Mike Biotech: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Mike Biotech: Legal Opinion of Shanghai AllBright Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Mike Biotech Co., Ltd.
Mike Biotech: Announcement on obtaining a product registration certificate for the company\'s new products
Mike Biotech: Prompt Announcement on Convening the First Extraordinary General Meeting of Shareholders in 2025
Mike Biotech: Announcement on obtaining a product registration certificate for the company\'s new products
Mike Biotech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Mike Biotech: Fifth Board Nomination Committee\'s Review Opinions on the Eligibility of Independent Director Candidates
Mike Biotech: Announcement on the election of the Board of Supervisors for a new term
Mike Biotech: Announcement on Board Elections for a New Term
Mike Biotech: Announcement on the Election of Staff Representative Supervisors for the 6th Board of Supervisors
Mike Biotech: Announcement on obtaining a product registration certificate for the company\'s new products
Mike Biotech: Announcement on the wholly-owned subsidiary\'s new product obtaining a product registration certificate
Mike Biotech: Announcement on obtaining a product registration certificate for the company\'s new products
Mike Biotech: Announcement on obtaining a product registration certificate for the company\'s new products
Mike Biotech: Legal Opinion of Shanghai AllBright Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Mike Biotech Co., Ltd.
Mike Biotech: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Mike Biotech: Prompt Announcement on Convening the 2024 Second Extraordinary General Meeting of Shareholders
Mike Biotech: An indicative announcement on the disclosure of the “2024 Third Quarter Report”
Mike Biotech: Announcement on the progress of cooperation between the company and the German Kaijie NGS project and the completion of the liquidation and cancellation of Mackay Gene Technology Co., Ltd.